FDA Approved: POTASSIUM CITRATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Potassium Citrate from Rising Pharma Holdings, Inc., under ANDA077440.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis
• Renal Tubular Acidosis

Drugs mentioned

• POTASSIUM CITRATE (Potassium citrate)

Snippet

SUPPL AP for POTASSIUM CITRATE (POTASSIUM CITRATE)